What is the purpose of this trial?
This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in pediatric patients with moderately to severely active CD who are treated as recommended in the local product label.
Ages: 6 - 30 years
Dates: 11/13/2015 - 04/01/2030
Last Updated: 02/22/2018
Study HIC#: 1509016499REG